TrialArthritis & rheumatology (Hoboken, N.J.)2017

A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Giant Cell Arteritis.

Carol A Langford et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.